Navigation Links
Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
Date:2/26/2009

2008 2007 2008 2007 (unaudited) Numerator: Pro forma net income allocable to common stockholders $5,350 $4,674 $31,356 $13,353 Denominator: Pro forma weighted average shares of common stock outstanding, net 16,587 10,367 16,399 2,756 Adjustments to reflect the weighted average effect of the assumed conversion of convertible preferred stock - 3,957 - 9,249 Pro forma weighted average shares of common stock outstanding, net - basic 16,587 14,324 16,399 12,005 Dilutive effect of common equivalent shares 1,180 1,572 1,254 1,549 Pro forma weighted average shares of common stock outstanding, net - diluted 17,767 15,896 17,653 13,554 Pro forma net income per share: Basic $0.32 $0.33 $1.91 $1.11 Diluted $0.30 $0.29 $1.78 $0.99 (1) As a result of the conversion of the Company's preferred stock into 11,032 shares of common stock upon completion of the Company's initial public offering in November 2007, there is a lack of comparability in the basic and diluted net income per share amounts for the periods presented above. For calculations of the pro forma net income per share for the periods presented, see Note 1 in the notes to consolidated financial statements included in the Annual Report on Form 10-K.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
2. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
3. Genoptix Announces the Addition of New Members to Board of Directors
4. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
5. Genoptix Reports Strong Financial Results for First Quarter 2008
6. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
7. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
8. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
9. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
10. Genoptix Announces Pricing of Secondary Public Offering
11. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 (HealthDay News) --,The time at which heart ... chances for survival, new research suggests. Showing up ... during holidays is associated with a 13 percent higher ... researchers report. Every year, more than 250,000 people ... type of heart attack, which is caused by a ...
(Date:7/29/2014)... Randy Dotinga HealthDay Reporter ... most children take on a task, various brain connections ... activity in kids with autism, according to a small ... of autism displayed even less of this "brain flexibility," ... often causes difficulty when children with autism are faced ...
(Date:7/29/2014)... 29, 2014 As the Ebola outbreak in ... partners to both purchase critical emergency supplies locally, as well ... Liberia. These supplies will contain materials used to control the ... populated areas of the country. , With a large ... response to the Ebola outbreak in the region. The current ...
(Date:7/29/2014)... (July 29, 2014) Using quality improvement measures in ... England Cardiovascular Disease Study Group, researchers have found a ... procedure with contrast dye. , Currently, 7-15 percent of ... contrast-dye end up with kidney injury, which can result ... to temporary or permanent dialysis, says a study published ...
(Date:7/29/2014)... July 29, 2014 Tylenol lawsuits ... who allegedly suffered serious liver injuries due to ... forward in a multidistrict litigation underway in U.S. ... LLP reports. According to an Order dated July ... pertaining to bellwether case and discovery issues. Among ...
Breaking Medicine News(10 mins):Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3Health News:Reducing kidney injury using a quality improvement method 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4
... all think we know a lot about vitamins, minerals ... studies have created confusion regarding their importance; a simple ... is that “Vitamins and other nutrients, including calcium and ... ,Stressing the point is Dr. Joseph C. Maroon, ...
... forefront of the mission to translate discoveries in basic sciences ... schools to have been chosen to receive a collective grant ... ,"The gap between basic biology and medical practice is ... education at the School of Medicine and principal investigator of ...
... in Russia has been witness to the death of more ... has hit the south of Russia.// ,According to ... Jan 25 and Feb 1, almost 350,000 birds have died ... 76,000 at the Makhachkalinskaya farm between Feb. 6 and Feb. ...
... response of MPs in favor of the proposed smoking ban in ... would be imposed by the summer of next year in the ... 184 has been achieved when the issue of smoking ban extension ... Following implementation of the law, both the public and club/pub workers ...
... mammalian protein called Rad9 could hold the key to killing ... at Washington University School of Medicine in St. Louis. Rad9 ... DNA, but it is now fund to be a "repairman" ... ,That is why reserachers are now ...
... the world's most common liver infection. It spreads easily and ... ,It causes liver cirrhosis, // liver failure and liver ... of the world's population, has been infected with the hepatitis ... are chronic carriers of the virus. Normally in case of ...
Cached Medicine News:Health News:Never undermine the importance of calcium and Vitamin D 2Health News:Getting Basic Science to Work For Medicine 2Health News:Switching Off Protein Could Play Key Role In Success Of Radiation Therapy For Cancer 2
(Date:7/29/2014)... 29, 2014 New high priced hepatitis C ... by a projected $2.9 to $5.8 billion next year, ... Milliman released today by the Pharmaceutical Care Management Association ... increase by as much as 8.6 percent in 2015 ... Sovaldi and Olysio. The study finds that ...
(Date:7/29/2014)... , July 29, 2014 Numotion,s Board of Directors ... Swinford will be the company,s new Chief Executive Officer. ... 22-year career at GE where he worked primarily for GE ... revenue to over $5 billion. His most recent position was ... "I am thrilled to join Numotion," said ...
(Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Numotion Names Mike Swinford CEO 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... cells that multiply and migrate in the, embryo to ... a finding, that suggests that these cells might ... MEMPHIS, Tenn., Oct. 3 Investigators at St.,Jude Children,s ... the mammalian lymphatic vasculature -- the network of vessels ...
... Peptimmune, Inc. a privately,held biotechnology company, announced that ... trial to evaluate the safety, tolerability,pharmacokinetics and pharmacodynamics ... of multiple sclerosis and other autoimmune diseases. ... placebo controlled,randomized study will involve 56 healthy male ...
Cached Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis 2
CDIs Ultra-Comfort Bra™ is designed with special single needle stitching that places the cup seams away from critical surgical sites....
Post-Surgical compression garments...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
Medicine Products: